Enlargement of Actavis Planned in Iceland Skip to content

Enlargement of Actavis Planned in Iceland

Icelandic pharmaceutical company Actavis is planning to increase its factory in Iceland by half. Today the factory can produce nearly one billion pills per year but the production capacity will increase to 1.5 billion pills after the changes have been carried through.

The headquarters of Actavis. Photo by Páll Kjartansson.

Assistant director of Actavis Group Gudbjörg Edda Eggertsdóttir told Morgunbladid that the enlargement is likely to happen this year and that a final decision on the changes will be made within a few weeks’ time.

Around 580 people are employed by Actavis in Iceland and almost 11,000 worldwide. The planned enlargement would create more jobs in Iceland.

However, the number of employees won’t increase in direct consistency with the enlargement, Eggertsdóttir said, explaining that the rationalization involves that the production capacity can be increased without a significant increase in employees.

Actavis operates 16 factories in different countries and Eggertsdóttir said it is most economically beneficial to enlarge the factory in Iceland as it has a permit to produce most of Actavis’ new pharmaceuticals because the company’s development center is located here.

Sign up for our weekly newsletter

Get news from Iceland, photos, and in-depth stories delivered to your inbox every week!

* indicates required

Subscribe to Iceland Review

In-depth stories and high-quality photography showcasing life in Iceland!

Share article